Clinician's Guide to Prevention and Treatment of Osteoporosis

被引:2519
作者
Cosman, F. [1 ,7 ]
de Beur, S. J. [2 ]
LeBoff, M. S. [3 ]
Lewiecki, E. M. [4 ]
Tanner, B. [5 ]
Randall, S. [6 ]
Lindsay, R. [1 ,7 ]
机构
[1] Helen Hayes Hosp, W Haverstraw, NY 10993 USA
[2] Johns Hopkins Bayview Med Ctr, Baltimore, MD USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
[5] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[6] Natl Osteoporosis Fdn, Washington, DC USA
[7] Columbia Univ, Dept Med, New York, NY USA
关键词
Diagnosis; Guide; Osteoporosis; Prevention; Treatment; MONTHLY ORAL IBANDRONATE; POSTMENOPAUSAL WOMEN; FRACTURE RISK; VITAMIN-D; RANDOMIZED-TRIAL; BREAST-CANCER; VERTEBRAL FRACTURES; ZOLEDRONIC ACID; BONE LOSS; BAZEDOXIFENE/CONJUGATED ESTROGENS;
D O I
10.1007/s00198-014-2794-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Clinician's Guide to Prevention and Treatment of Osteoporosis was developed by an expert committee of the National Osteoporosis Foundation (NOF) in collaboration with a multispecialty council of medical experts in the field of bone health convened by NOF. Readers are urged to consult current prescribing information on any drug, device, or procedure discussed in this publication.
引用
收藏
页码:2359 / 2381
页数:23
相关论文
共 101 条
[61]   Guideline for the prevention of falls in older persons [J].
Lundebjerg, N ;
Rubenstein, LZ ;
Kenny, RA ;
Koval, KJ ;
Martin, FC ;
Tinetti, ME ;
Apple, DF ;
Cantrill, JA ;
Chang, JT ;
Duncan, PW ;
Ellis, M ;
Hogan, T ;
Lipsitz, LA ;
Rich, MW ;
Strumpf, NE ;
Wallace, WA ;
Young, A .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (05) :664-672
[62]   Zoledronic acid and clinical fractures and mortality after hip fracture [J].
Lyles, Kenneth W. ;
Colon-Emeric, Cathleen S. ;
Magaziner, Jay S. ;
Adachi, Jonathan D. ;
Pieper, Carl F. ;
Mautalen, Carlos ;
Hyldstrup, Lars ;
Recknor, Chris ;
Nordsletten, Lars ;
Moore, Kathy A. ;
Lavecchia, Catherine ;
Zhang, Jie ;
Mesenbrink, Peter ;
Hodgson, Patricia K. ;
Abrams, Ken ;
Orloff, John J. ;
Horowitz, Zebulun ;
Eriksen, Erik Fink ;
Boonen, Steven .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) :1799-1809
[63]   Estrogen therapy and coronary-artery calcification [J].
Manson, JoAnn E. ;
Allison, Matthew A. ;
Rossouw, Jacques E. ;
Carr, J. Jeffrey ;
Langer, Robert D. ;
Hsia, Judith ;
Kuller, Lewis H. ;
Cochrane, Barbara B. ;
Hunt, Julie R. ;
Ludlam, Shari E. ;
Pettinger, Mary B. ;
Gass, Margery ;
Margolis, Karen L. ;
Nathan, Lauren ;
Ockene, Judith K. ;
Prentice, Ross L. ;
Robbins, John ;
Stefanick, Marcia L. ;
Rossouw, J. E. ;
Ludlam, S. ;
Cochrane, B. B. ;
Hunt, J. R. ;
Lund, B. ;
Prentice, R. ;
Carr, J. J. ;
O'Rourke, C. ;
Du, L. ;
Pillsbury, S. ;
Hightower, C. ;
Ellison, R. ;
Tan, J. ;
Wassertheil-Smoller, S. ;
Magnani, M. ;
Noble, D. H. ;
Dellicarpini, T. ;
Manson, J. E. ;
Bueche, M. ;
McGinnis, A. D. ;
Rybicki, F. J. ;
Assaf, A. R. ;
Sloane, G. ;
Phillips, L. S. ;
Butler, V. ;
Huber, M. ;
Vitali, J. ;
Hsia, J. ;
LeBrun, C. ;
Palm, R. ;
Embersit, D. ;
Whitlock, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (25) :2591-2602
[64]   Continuing outcomes relevant to evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene [J].
Martino, S ;
Cauley, JA ;
Barrett-Connor, E ;
Powles, TJ ;
Mershon, J ;
Disch, D ;
Secrest, RJ ;
Cummings, SR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23) :1751-1761
[65]   Alcohol and bone: review of dose effects and mechanisms [J].
Maurel, D. B. ;
Boisseau, N. ;
Benhamou, C. L. ;
Jaffre, C. .
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) :1-16
[66]   Effect of risedronate on the risk of hip fracture in elderly women [J].
McClung, MR ;
Geusens, P ;
Miller, PD ;
Zippel, H ;
Bensen, WG ;
Roux, C ;
Adami, S ;
Fogelman, I ;
Diamond, T ;
Eastell, R ;
Meunier, PJ ;
Reginster, JY ;
Wasnich, RD ;
Greenwald, M ;
Kaufman, J ;
Chestnut, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :333-340
[67]   Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision [J].
McLellan, A. R. ;
Wolowacz, S. E. ;
Zimovetz, E. A. ;
Beard, S. M. ;
Lock, S. ;
McCrink, L. ;
Adekunle, F. ;
Roberts, D. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (07) :2083-2098
[68]   How many women have osteoporosis? (Reprinted from Journal Bone & Mineral Research, vol 7, pg 1005, 1992) [J].
Melton, LJ ;
Chrischilles, EA ;
Cooper, C ;
Lane, AW ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (05) :886-892
[69]   Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study [J].
Miller, PD ;
McClung, MR ;
Macovei, LV ;
Stakkestad, JA ;
Luckey, M ;
Bonvoisin, B ;
Reginster, JY ;
Recker, RR ;
Hughes, C ;
Lewiecki, EM ;
Felsenberg, D ;
Delmas, PD ;
Kendler, DL ;
Bolognese, MA ;
Mairon, N ;
Cooper, C .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) :1315-1322
[70]   Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women [J].
Mirkin, S. ;
Komm, B. S. ;
Pan, K. ;
Chines, A. A. .
CLIMACTERIC, 2013, 16 (03) :338-346